focus -WSS

focus

author：knowledge 2025-09-28 21:06:28 - browse：9954

The human gut teems with bacteria and other colorful microbes. — NIH

One of the indignities of getting older is the way your body’s defenses against microbes begin to break down, leaving you extra vulnerable to infection. Researchers studying the ways these systems change with age refer to them collectively as “immunosenescence,” or, more poetically, the “twilight of immunity.” But even as scientific understanding of the phenomenon has grown over the past decade, the forces driving it remain murky.

One theory is that it all starts in the bone marrow, where a primitive reserve of stem cells replenishes the ranks of blood and immune cells to the tune of about 500 billion new cells every day. Some of these hematopoietic stem cells, or HSCs, are more likely to become long-lived stewards of immune memory like B cells and T cells; others are more likely to give rise to blood cells and front-line immune defenders. They all work in concert to get the balance right. As people age, though, one lineage of HSCs starts to dominate, throwing the equilibrium off-kilter.

On Wednesday, a team of scientists at Stanford University and the National Institutes of Health Rocky Mountain Laboratories reported in Nature that this age-associated imbalance in HSCs is to blame for a cascade of downstream declines in immune function. And by restoring a youthful balance of these cells with injections of antibodies, they were able to rejuvenate the immune systems of older mice — enabling them to better fend off viral attacks.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

focus

WSS

Why did Pfizer dish out millions for a Super Bowl ad?

Key House Republican on health care plans exit from Congress

Why did Pfizer dish out millions for a Super Bowl ad?

Medicare Advantage proposed rates disappoint insurers

How to ethically and practically extend health care to all

Pharma showers House GOP doctor with campaign cash

hotspot

focus

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Physicians aren't 'burning out.' They're suffering from moral injury

Novavax promises a turnaround & Lilly roils the obesity market

Heart disease in astronauts blamed on cosmic radiation

Duchenne breakthrough therapy leaves behind pioneering families

Gilead might be held responsible for not developing a drug

Apple is now the first public company to be valued at $3 trillion

Key House Republican on health care plans exit from Congress

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Biden report: The neurospychology of memory and aging

focus

'Revelatory' study finds a smoking impact that remains after quitting

Chris Christie meets with Zelenskyy during Ukraine trip

Gilead might be held responsible for not developing a drug

Flint parents haunted by uncertainty, fears of lead poisoning

Chris Christie meets with Zelenskyy during Ukraine trip

Biotech startup Celsius cuts 75% of staff ahead of first trial start

explore

entertainment

focus

hotspot